Gordana Kostic

Gordana Kostic

Auto-generated profile, based on publicly available information

Gordana Kostic

Pedijatrijska klinika, Klinički centar, Kragujevac

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2010 in Hormone Research in Paediatrics
Verified
Journal Article
Closed access
LSL. Saranac
L. Saranac
SZS. Zivanovic
S. Zivanovic
ZRZ. Radovanovic
Z. Radovanovic
GKG. Kostic
G. Kostic
IMI. Markovic
I. Markovic
PMP. Miljkovic
P. Miljkovic
Background: Hyperprolactinemia is the most common disturbance in pituitary gland secretion. Functional diversity of prolactin action is responsible for different initial clinical expressions of hyperprolactinemia. Patients and Methods: We investigated causes of hyperprolactinemia in 11 children and adolescents (6 females and 5 males), aged from 1.5 to 17.5 years. Children with primary hypothyroidism, iatrogenic hyperprolactinemia and adolescents with polycystic ovaries were excluded. Results: Four patients had short stature or growth deceleration, the same number were clinically obese, 2 adolescent girls had secondary amenorrhea, 1 girl had premature thelarche and gynecomastia, and hypogonadism was the indication for the endocrinologic examination of two adolescent boys. Delayed pubertal development was present in both sexes. Hyperprolactinemia was also found in the youngest girl with multiple ovarian cysts. A very high prolactin (PRL) level was documented in the PRL profile of all patients (mean 2,553.00 ± 1,020.97 mU/l). MRI of the pituitary was indicated and revealed 4 microprolactinomas, one congenital hypophyseal cyst and one tumor of the hypothalamus. Dopamine agonist treatment was efficacious in almost all the patients. Conclusion: Hyperprolactinemic children expressed a wide variety of initial clinical presentations. The most common were growth and puberty disorders and obesity. PRL determination should be included in investigation protocols of obese and short stature children.

29 June 2016 in World Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
IFIvana Filipovic
Ivana Filipovic
Marco CaminatiMarco Caminati
Marco Caminati
GKGordana Kostić
Gordana Kostić
ĐFĐorđe Filipović
Đorđe Filipović
ZŽZorica Živković
Zorica Živković

16 November 2010 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
EGEmilija Golubovic
Emilija Golubovic
PMPredrag Miljkovic
Predrag Miljkovic
SZSasa Zivic
Sasa Zivic
DJDanijela Jovancic
Danijela Jovancic
GKGordana Kostic
Gordana Kostic

28 February 2010 in Early Human Development
Verified
Journal Article
Closed access
BBBojko Bjelakovic
Bojko Bjelakovic
SIStevan Ilic
Stevan Ilic
LDLidija Dimitrijevic
Lidija Dimitrijevic
BMBranislav Milovanovic
Branislav Milovanovic
GKGordana Kostic
Gordana Kostic
SLStevo Lukic
Stevo Lukic

25 October 2016 in The Turkish Journal of Pediatrics
Verified
Journal Article
Open access
ZIZoran Igrutinovic
Zoran Igrutinovic
RMRaša H. Medovic
Raša H. Medovic
SMSlavica Markovic
Slavica Markovic
GKGordana Kostic
Gordana Kostic
ZRZorica Raskovic
Zorica Raskovic
BVBiljana Vuletic
Biljana Vuletic
Rosai-Dorfman disease is a rare benign histiocytic disorder that arises predominantly in lymph nodes with fever and malaise, but can affect various organs, with or without lymphadenopathy. Solitary extranodal skeletal lesions are extremely rare. Herein, we describe a case of isolated disease of thoracic spine, with vertebral body fracture. A 14-year-old girl presented with cervical back pain for about one month as the only symptom. There was no lymphadenopathy. Results of laboratory tests were within reference ranges. The radiological examinations revealed collapse, osteolytic lesion and compressive fracture, which reduced vertical diameter of C4 vertebral body. The patient made a complete recovery after a limited C4 laminectomy, spondylodesis C3/C5 vertebra and biopsy of the lesion. Histologically, nonspecific cellular milieu and atypical histiocytic proliferation with emperipolesis, with CD68 and S100 positivity, confirmed a diagnosis of Rosai-Dorfman disease. Isolated extranodal skeletal Rosai-Dorfman disease should be considered among the differential diagnoses of similar changes, such as Langerhans cell histiocytosis, Erdheim-Cheister disease, eosinophilic granuloma, osteomyelitis, metastasis and lymphoma.

1 January 2011 in Vojnosanitetski Pregled
Verified
Journal Article
Open access
PDF file
MPMarina Petrovic
Marina Petrovic
NINevenka Ilic
Nevenka Ilic
OLOlivera Loncarevic
Olivera Loncarevic
ICIvan Cekerevac
Ivan Cekerevac
ZLZorica Lazic
Zorica Lazic
GKGordana Kostic
Gordana Kostic
Introduction/Aim. Lung cancer is a leading cause of mortality among patients with carcinomas. The aim of this study was to point out risk factors for brain metastases (BM) appearance in patients with IIIA (N2) stage of nonsmall cell lung cancer (NSCLC) treated with three-modal therapy. Methods. We analyzed data obtained from 107 patients with IIIA (N2) stage of NSCLC treated surgically with neoadjuvant therapy. The frequency of brain metastases was examined regarding age, sex, histological type and the size of tumor, nodal status, the sequence of radiotherapy and chemotherapy application and the type of chemotherapy. Results. Two and 3-year incidence rates of BM were 35% and 46%, respectively. Forty-six percent of the patients recurred in the brain as their first failure in the period of three years. Histologically, the patients with nonsquamous cell lung carcinoma had significantly higher frequency of metastases in the brain compared with the group of squamous cell lung carcinoma (46% : 30%; p = 0.021). Examining treatment-related parameters, treatment with taxane-platinum containing regimens was associated with a lower risk of brain metastases, than platinum-etoposide chemotherapy regimens (31% : 52%; p = 0.011). Preoperative radiotherapy, with or without postoperative treatment, showed lower rate of metastases in the brain compared with postoperative radiotherapy treatment only (33% : 48%; p = 0.035). Conclusion. Brain metastases are often site of recurrence in patients with NSCLC (IIIA-N2). Autonomous risk factors for brain metastases in this group of patients are non-squamous NSCLC, N1-N2 nodal status, postoperative radiotherapy without preoperative radiotherapy.